BTIG Initiates Coverage On Pulse Biosciences with Buy Rating, Announces Price Target of $70

Benzinga Newsdesk www.benzinga.com Positive 57.7%

Neg 0% Neu 0% Pos 57.7%

BTIG analyst Marie Thibault initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Buy rating and announces Price Target of $70.